lucarista /
16 January 2015Asia

Cipla appeals against Onbrez decision

Cipla has appealed against a decision by the Delhi High Court that blocked the generic drug maker from marketing copies of Novartis’s respiratory drug Onbrez (indacaterol) in India.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at